Interview with Dr. Shah
This recent interview with Dr. Shah who runs THTX’s PDC trial was done early August.
It is encouraging the way he referenced to their ABC news coverage re first patient dosed by THTX’s PDC and future important aspects of that trial.
“Just few months ago, we were on ABC News. And the phase one trial we brought was the first one in the United States that we have done with this company and this particular drug. It was the first patient in the country at our center, as well as the first patient in the world, with this new drug. So, we were really excited about that part. Being able to offer initial trial to the patients is very, very critical and important for the patient care.”
Gettysburg Cancer Center Expands Clinical Trial Resources With Help of OneOncology